摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

NS 28

中文名称
——
中文别名
——
英文名称
NS 28
英文别名
NS28;(1S,2S,6R,14R,15R)-5-(cyclopropylmethyl)-13,17-dioxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-triene-11,15-diol
NS 28化学式
CAS
——
化学式
C21H25NO4
mdl
——
分子量
355.434
InChiKey
NOOSMRUESWMKBO-VHQPJYBDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    26
  • 可旋转键数:
    2
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    62.2
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: μ, κ, and putative ε opioid receptor antagonists
    作者:Hideaki Fujii、Akio Watanabe、Toru Nemoto、Minoru Narita、Kan Miyoshi、Atsushi Nakamura、Tsutomu Suzuki、Hiroshi Nagase
    DOI:10.1016/j.bmcl.2008.11.050
    日期:2009.1
    A twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer, NS29, was synthesized from a naltrexone derivative. The structure of compound 8, the precursor of NS29, was determined by X-ray crystallography. Monomeric NS28 showed mu opioid receptor antagonist activity, whereas dimeric NS29, consisting of two NS28 units, showed antagonist activities for mu, kappa, and the putative epsilon opioid receptor agonists. Twin drug NS29 and its derivatives are expected to be unique pharmacological tools for investigation of opioid receptor types (C) 2008 Elsevier Ltd. All rights reserved.
  • Synthesis of opioid ligands having oxabicyclo[2.2.2]octane and oxabicyclo[2.2.1]heptane skeletons
    作者:Hiroshi Nagase、Akio Watanabe、Toru Nemoto、Naoshi Yamamoto、Yumiko Osa、Noriko Sato、Kenji Yoza、Toshitsugu Kai
    DOI:10.1016/j.tetlet.2007.02.022
    日期:2007.4
    Two types of novel skeletons were synthesized from morphinan and 4,5-epoxymorphinan derivatives by using stable and unstable sulfur ylide.
    通过使用稳定和不稳定的硫叶立德,从吗啡喃和4,5-环氧吗啡喃衍生物合成了两种新型骨架。
查看更多

同类化合物

普罗啡烷 (9R,10R)-15-(环丙基甲基)-10-甲基-11-氧杂-17-氮杂四环[7.5.3.01,10.0(2,7)]十七-2,4,6-三烯-4-醇 3-methoxy-14β-hydroxy-6-oxamorphinan (1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indole (+)-14β-Hydroxy-3-methoxy-17-methyl-6-oxamorphinan N-Propargyl-3-methoxy-14β-methyl-8-oxamorphinan N-Propargyl-3-hydroxy-14β-methyl-8-oxamorphinan NS 28 17-cyclopropylmethyl-7,14α-epoxy-7,14-seco-8-nor-morphinan-3-ol 17-cyclopropylmethyl-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-phenyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one NS22 (1S,5R,13R,14R,17S)-4-methyl-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-trien-10-ol KNT-63 (1R,9R,10S,13R)-18-(cyclopropylmethyl)-4-hydroxy-19-oxa-18-azapentacyclo[7.6.3.1^{10,13}.0^{1,10}.0^{2,7}]nonadeca-2(7),3,5-trien-14-one (1S,9R,10R)-17-(cyclopropylmethyl)-11-hydroxy-4-methoxy-12-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one 17-cyclopropylmethyl-6α,14-epoxy-4,5α-epoxy-3-benzyloxymorphinan Proxorphan tartrate (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one (4bR,8R,8aS,9aS,11aS,11bR)-7-allyl-11-benzyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-methyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-isobutyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (1S,5R,13R,14R,17S)-4-(cyclopropylmethyl)-10-methoxy-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-triene (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-(cyclopropylmethyl)-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one 3-methoxy-10α,17-dimethyl-6-oxamorphinan 3-methoxy-17-methyl-10-methylene-6-oxamorphinan rac-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (1R,9S,10S)-17-(cyclopropylmethyl)-13-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10R)-10,17-dimethyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10S)-17-(cyclopropylmethyl)-10-methyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol 16-(Cyclopropylmethyl)-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 3-Hydroxy-17-methyl-8-oxamorphinan 12,16-Dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol rac-(6Ξ)-6,14β-epoxy-17-methyl-7,14-seco-8-nor-morphinane (1R,9R,10S)-16-cyclobutyl-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 1-[(1R,9R,10S)-10,16-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2,4,6-trien-12-yl]-N,N-dimethylmethanamine;hydrochloride (8S)-6-benzyl-21-(cyclopropylmethyl)-15-hydroxy-11,13,25-trioxa-6,21-diazahexacyclo[12.9.1.12,8.01,9.02,20.018,24]pentacosa-14,16,18(24)-trien-7-one (3S)-5,20-bis(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (3S)-5-benzyl-20-(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-16-ol [(3R,6S)-14-hydroxy-19-(2-hydroxy-2-methylpropyl)-7-oxa-4,19-diazahexacyclo[7.7.3.13,8.01,8.02,6.011,16]icosa-11(16),12,14-trien-4-yl]-phenylmethanone [(3S)-20-(cyclopropylmethyl)-5-(4,6-dimethyl-1,2-dihydropyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-yl] trifluoromethanesulfonate 3-[(3S)-20-(cyclopropylmethyl)-15-methoxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-triene-5-carbonyl]benzonitrile [(3S)-20-(cyclopropylmethyl)-15-hydroxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-5-yl]-(2-fluorophenyl)methanone (1R,3S,9S,10R)-20-(cyclopropylmethyl)-5-(4,6-dimethylpyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-11-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-12-ol (1R,2S,3S,6R,9S,10R)-20-(cyclopropylmethyl)-5-(2-phenylethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(immoethano)-1,5a-epoxynaphtho[1,2-e]indole-10,12-diol